Disclosures for "First-in-Human Trial of NRTX-1001 GABAergic Interneuron Cell Therapy for Treatment of Focal Epilepsy - Emerging Clinical Trial Results"
-
Dr. Babu has nothing to disclose.
-
The institution of Dr. Beach has received research support from Neurona.
-
-
Kim Burchiel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurona Therapeutics. Kim Burchiel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ClearPoint Neuro. Kim Burchiel has received intellectual property interests from a discovery or technology relating to health care. Kim Burchiel has received publishing royalties from a publication relating to health care. Kim Burchiel has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Harvard University.
-
Dr. Luedke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bright Health. Dr. Luedke has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Guidepoint. The institution of Dr. Luedke has received research support from US NAVY. The institution of Dr. Luedke has received research support from Neurona. The institution of Dr. Luedke has received research support from Xenon.
-
Dr. O'Dwyer has nothing to disclose.
-
Sepehr Sani has nothing to disclose.
-
Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Shih has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Shih has received research support from Neurona. The institution of Dr. Shih has received research support from NCGS, Inc. Dr. Shih has a non-compensated relationship as a Test Writing Committee Member with ABPN that is relevant to AAN interests or activities.
-
Dr. Southwell has nothing to disclose.
-
Dr. Spencer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace Inc. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. Dr. Spencer has received publishing royalties from a publication relating to health care. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Faculty in Teaching Course supported by unrestricted educational grants with Creative Education Concepts.
-
Dr. Banik has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Banik has stock in Neurona Therapeutics.
-
Dr. Bershteyn has received personal compensation for serving as an employee of Neurona therapeutics . Dr. Bershteyn has received stock or an ownership interest from Neurona therapeutics . The institution of Dr. Bershteyn has received research support from CIRM.
-
Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
-
Dr. Bulfone has received personal compensation for serving as an employee of Neurona Therapeutics Inc.
-
Miss Feld has received personal compensation for serving as an employee of Neurona Therapeutics.
-
Ms. Finefrock has received personal compensation for serving as an employee of Neurona Therapeutics.
-
Luis Fuentealba has received personal compensation for serving as an employee of Neurona Therapeutics.
-
Dr. Hixson has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Hixson has received personal compensation for serving as an employee of Nile Ai. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NextSense Inc.. Dr. Hixson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seer Medical. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expert Institute.
-
Miss Hosford has received personal compensation for serving as an employee of Neurona Therapeutics.
-
Dr. Jung has received personal compensation for serving as an employee of Neurona Therapeutics.
-
Dr. Kowal has received personal compensation for serving as an employee of Neurona Theraputics.
-
Ms. Kriks has received personal compensation for serving as an employee of Neurona Therapeutics. Ms. Kriks has stock in Neurona Therapeutics. Ms. Kriks has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Larios has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Larios has stock in Neurona Therapeutics.
-
Dr. Lee has received personal compensation for serving as an employee of Neurona Therapeutics.
-
Mrs. Madrid has received personal compensation for serving as an employee of Neurona Therapeutics, Inc. Mrs. Madrid has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurona Therapeutics, Inc.
-
Mr. MAURY has received personal compensation for serving as an employee of neurona therapeutics.
-
Catherine Priest has received personal compensation for serving as an employee of Neurona Therapeutics. Catherine Priest has received stock or an ownership interest from Neurona Therapeutics.
-
Mr. Shevchuk has received personal compensation for serving as an employee of Neurona Therapeutics.
-
Dr. Shevchuk has received personal compensation for serving as an employee of Neurona Therapeutics.
-
Cory Nicholas has received personal compensation for serving as an employee of Neurona Therapeutics. Cory Nicholas has received stock or an ownership interest from Neurona Therapeutics. Cory Nicholas has received intellectual property interests from a discovery or technology relating to health care.